$KIDS

Squadron Capital LLC sold $525K of KIDS

Squadron Capital LLC sold 22,500 shares of ORTHOPEDIATRICS CORP (KIDS) at $23.35 ($0.53M total) on 2026-09-02. Filed jointly with Squadron Capital Holdings LLC (10% owner).

Original reporting
SEC EDGAR · Squadron Capital LLC, Squadron Capital Holdings LLC
Published Sep 4, 2026, 8:42 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 4, 2026, 9:12 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$KIDS
Bearish
medium confidence
Mentioned
$KIDS
Relevance
5/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$KIDSBearishLow
01

Why it matters

The disclosed sale is modest in size and unlikely to move the stock significantly, but it adds a data point for tracking insider activity.

02

Market read

Provides a fresh insider transaction for KIDS; modest relevance for short‑term traders.

03

What to watch

Potential tax‑loss harvesting or fund liquidity needs may have driven the sale.

Relevance 5/10Novelty 6/10Timing: post‑market filing on 2026‑09‑04

Background

Form 4 filings disclose insider transactions; investors monitor them for signals about management confidence.

Company-level read

Ticker impact

$KIDSBearishMedium confidence
Context

Squadron Capital LLC sold 22,500 shares of Orthopedics Corp (KIDS) for $525,375 in an open‑market sale filed on Form 4.

Expected impact

Potential slight downward pressure, likely limited to a few basis points.

Evidence & confidence

The sale represents a 0.35% reduction of holdings; market may view it as a minor bearish cue.

Market effects

Minimal impact on the orthopedics/medical device sector; no broader industry signal.

Limited to U.S. equity markets where KIDS trades.

Low; the transaction is company‑specific and does not affect global markets.

Counterpoint

The sale could be a routine portfolio rebalancing rather than a confidence issue.

Key entities

  • Squadron Capital LLC

    10% owner of Orthopedics Corp filing the sale.

  • Orthopedics Corp

    Medical device company listed on NASDAQ under ticker KIDS.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$KIDSHighAI 8/10

OrthoPediatrics (KIDS) Crosses $70M as Guidance Climbs Higher

OrthoPediatrics (KIDS) reported Q2 revenue of $70.5M, up 15% YoY, and raised 2026 guidance to $265M-$269M. Trauma and Deformity revenue grew 26%, while international sales rose 22%. Despite higher expenses, gross margin expanded to 74% and adjusted EBITDA doubled to $6.8M. Net loss remained at $7.2M, and cash reserves declined to $47.9M.

$KIDSMed

OrthoPediatrics Corp. Q2 2026 Earnings Call Summary

OrthoPediatrics reported Q2 2026 progress toward a “financial inflection point,” citing record adjusted EBITDA margins near 10% and a shift toward positive free cash flow. Trauma and Deformity revenue grew 26% on implant share gains and early 3P Hip deployments. Management expects positive free cash flow in H2 2026 and FCF break-even or better for full-year 2026, with conservative timing assumptions for capital placements and international orders.